Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation

Transplantation Proceedings

Volumn 35, Issue 8, 2003, Pages 3042-3044

  Mukherjee, S ^a   Rogge, J ^a   Weaver, L ^a   Schafer, D F ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYCLOSPORIN A; FOLIC ACID; IMMUNOSUPPRESSIVE AGENT; PEGINTERFERON ALPHA2B; RIBAVIRIN; TACROLIMUS; VIRUS RNA;

ADULT; AGED; ANEMIA; ARTERY THROMBOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; ENDOCRINE DISEASE; FATIGUE; FEMALE; FOLLOW UP; GRAFT REJECTION; HEPATIC ARTERY; HEPATIC DECOMPENSATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER DISEASE; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MALE; PILOT STUDY; PLEURA EFFUSION; PRIORITY JOURNAL; PSYCHOSIS; RECURRENT DISEASE; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT WITHDRAWAL;

EID: 0346500873     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2003.10.083     Document Type: Article

References (5)

1. Ghobrial R.M. Retransplantation for recurrent hepatitis C. Liver Transpl. 8:2002;S38.
2. Samuel D., Bizollon T., Feray C., et al. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation a randomized study . Gastroenterology. 124:2003;642.
3. Manns M.P., Hutchinson J.G., Gordon S.C., et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C a randomised trial . Lancet. 358:2001;958.
4. Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl. 8:2002;S14.
5. Gane E. Treatment of recurrent hepatitis C. Liver Transpl. 8:2002;S28.